Vertex Pharmaceuticals
VRTX
VRTX
1,490 hedge funds and large institutions have $97.6B invested in Vertex Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 172 funds opening new positions, 608 increasing their positions, 517 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
7% less call options, than puts
Call options by funds: $718M | Put options by funds: $774M
1.67% less ownership
Funds ownership: 92.62% → 90.96% (-1.7%)
27% less funds holding in top 10
Funds holding in top 10: 41 → 30 (-11)
Holders
1,490
Holding in Top 10
30
Calls
$718M
Puts
$774M
Top Buyers
| 1 | +$1.59B | |
| 2 | +$920M | |
| 3 | +$366M | |
| 4 |
Jennison Associates
New York
|
+$354M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$176M |
Top Sellers
| 1 | -$1.17B | |
| 2 | -$975M | |
| 3 | -$589M | |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$391M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$347M |